Jerome Durso

2019

In 2019, Jerome Durso earned a total compensation of $4.3M as Chief Operating Officer at Intercept Pharmaceuticals, a 34% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$359,284
Option Awards$1,238,321
Salary$573,250
Stock Awards$2,089,570
Other$21,368
Total$4,281,793

Durso received $2.1M in stock awards, accounting for 49% of the total pay in 2019.

Durso also received $359.3K in non-equity incentive plan, $1.2M in option awards, $573.3K in salary and $21.4K in other compensation.

Rankings

In 2019, Jerome Durso's compensation ranked 2,737th out of 13,971 executives tracked by ExecPay. In other words, Durso earned more than 80.4% of executives.

ClassificationRankingPercentile
All
2,737
out of 13,971
80th
Division
Manufacturing
986
out of 5,695
83rd
Major group
Chemicals And Allied Products
325
out of 2,194
85th
Industry group
Drugs
264
out of 1,880
86th
Industry
Pharmaceutical Preparations
194
out of 1,392
86th

Pay ratio

Jerome Durso's Pay$4,281,793
Median Employee's Pay$239,066
Pay Ratio

18

to 1

In 2019, the annual total compensation of Jerome Durso was $4,281,793.

The annual total compensation of the median employee at Intercept Pharmaceuticals was $239,066.

The ratio of Jerome Durso's pay to the pay of median employee was therefore 18 to one.

Source: SEC filing on April 29, 2020.

Durso's colleagues

We found four more compensation records of executives who worked with Jerome Durso at Intercept Pharmaceuticals in 2019.

2019

Mark Pruzanski

Intercept Pharmaceuticals

Chief Executive Officer

2019

Ryan Sullivan

Intercept Pharmaceuticals

General Counsel

2019

Richard Kim

Intercept Pharmaceuticals

President, U.S. Commercial Strategic Marketing

2019

Sandip Kapadia

Intercept Pharmaceuticals

Chief Financial Officer

News

You may also like